Elana Thieme and Mark Mendoza, fourth-year graduate students in the Molecular and Cell Biology (MCB) PhD Program jointly ...

Crinetics Pharmaceuticals, Inc. today announced the first patient has been dosed in the Phase 1/2 study evaluating CRN09682 in patients with metastatic or locally advanced somatostatin receptor type 2 ...

Chemists have long been fascinated and frustrated by saxitoxin: a molecule that causes temporary paralysis by blocking the ...

Zentalis has taken a beating in 2025 to date, as the market continues to value their pipeline as a liability rather than an ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today positive topline results in its 13-week Phase II study evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist for the ...

Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM ESTCompany ParticipantsDietmar Berger - Chief ...

Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive ...

The fabrication of two-dimensional covalent organic framework films with uniform thickness, ordered structure and excellent semiconducting performance directly on substrates for applications in ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...

BackBiome honey-based probiotic formula combines seven researched bacterial strains including Bacillus subtilis to support ...

Two candidates will appear on the April 2026 ballot for the OKC Board of Education District 7 seat. The District 5 seat will ...